So first the “less good” news … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer | Tagged: OPKO, point of care, PSA, Sangia, test | 6 Comments »
-
-
-
-
-
-
- The "New" Prostate Cancer InfoLink has been developed to become a primary source of accurate, current, and topical information about prostate cancer for patients and their families.
A service of
Awards
Other PCI web sites
-
Disclaimer
News and information provided on this site should not be used for diagnosing or treating any health problem or disease.
The “New” Prostate Cancer InfoLink is intended for informational purposes only. It is not engaged in rendering medical advice or professional services and is not a substitute for professional care. If you have or suspect you may have a health problem, please consult your healthcare provider.
-
Hot Posts …
- Whole-pelvic radiation therapy for high-risk patients
- Fear of prostate cancer recurrence post-surgery
- Timing of initiation of ADT for men with biochemical progression after first-line surgery
- Rethinking risk stratification for radiation therapy
- AS research survey: your help still needed
- Helpful upcoming webinars this week
- Three helpful upcoming webinars
- Research on AS in management of prostate cancer: your input is important!
- Extending OS on initial ADT for men with mHSPC
- Lower salvage radiation dose — are outcomes the same?
- Brief, intense radiation and hormone therapy for very high-risk prostate cancer
- Major results of Phase III VISION trial announced
- Early data from the PEACE-1 trial
- FDA approves Pylarify for diagnosis of advanced/recurrent forms of prostate cancer
- Patient survey re active surveillance
… and Archives
Blog at WordPress.com. WP Designer.
